NKTR 8-K 2026-10-01
NEKTAR THERAPEUTICS (NKTR) 8-K dated 2026-10-01 — accession 0001213900-26-105453.
NEKTAR THERAPEUTICS (NKTR) is a biotechnology company listed on US.
NEKTAR THERAPEUTICS filed a 8-K on 2026-10-01. Accession 0001213900-26-105453.
This 8-K covers: Reg FD disclosure (Item 7.01), Exhibits (Item 9.01). SEC EDGAR holds the official filing and its exhibits.
Latest reported NKTR revenue for 2025-12-31 was $55.2M. Net income was -$164.1M. Revenue was down 43.9% from 2024-12-31 to 2025-12-31. NKTR currently screens at market cap $307.2M.
Not investment advice. The NKTR SEC hub lists recent forms. The stock page is the research view.